DRTS
Alpha Tau Medical Ltd.
NASDAQ · Healthcare · Biotechnology · IL
$13.23
−0.90%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-210.1%
Return on equity
-69.0%
Return on assets
-85.2%
Return on invested capital
0.00x
Asset turnover
-$26.7M
Cash from operations
$1.09
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026